The NaV1.7 sodium channel: from molecule to man

被引:434
|
作者
Dib-Hajj, Sulayman D. [1 ,2 ,3 ]
Yang, Yang [1 ,2 ,3 ]
Black, Joel A. [1 ,2 ,3 ]
Waxman, Stephen G. [1 ,2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA
[3] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA
关键词
VOLTAGE-GATED SODIUM; EXTREME PAIN DISORDER; CLOSED-STATE INACTIVATION; OF-FUNCTION MUTATIONS; ROOT GANGLION NEURONS; NEUROPATHIC PAIN; SENSORY NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; SLOW-INACTIVATION; PHARMACOLOGICAL MANAGEMENT;
D O I
10.1038/nrn3404
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The voltage-gated sodium channel Na(V)1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons. Na(V)1.7 accumulates at nerve fibre endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability. Genetic and functional studies have added to the evidence that Na(V)1.7 is a major contributor to pain signalling in humans, and homology modelling based on crystal structures of ion channels suggests an atomic-level structural basis for the altered gating of mutant Na(V)1.7 that causes pain.
引用
收藏
页码:49 / 62
页数:14
相关论文
共 50 条
  • [21] Regulation of the voltage-gated sodium channel Nav1.7 current in vitro
    Laedermann, Cedric
    Decosterd, Isabelle
    Abriel, Hugues
    SWISS MEDICAL WEEKLY, 2008, 138 (41-42) : 3S - 4S
  • [22] Drug screening reveals inhibitors of NaV1.7 sodium channels and a pain-relevant NaV1.7 variant
    Kesdogan, A.
    Raemisch, S.
    Kriegeskorte, S.
    Bott, R.
    Rolke, R.
    Koerner, J.
    Lampert, A.
    Hausmann, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S44 - S45
  • [23] Tramadol as a Voltage-Gated Sodium Channel Blocker of Peripheral Sodium Channels Nav1.7 and Nav1.5
    Bok, Chan-Su
    Kim, Ryeong-Eun
    Cho, Yong-Yeon
    Choi, Jin-Sung
    BIOMOLECULES & THERAPEUTICS, 2023, 31 (02) : 168 - 175
  • [24] Mapping the Nav1.7 Channel Interaction with the Conotoxin KIIIA
    Kimball, Ian H.
    Nguyen, Phuong T.
    Sack, Jon T.
    Yarov-Yarovoy, Vladimir
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 437A - 437A
  • [25] Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin
    Rice, Frank L.
    Albrecht, Phillip J.
    Wymer, James P.
    Black, Joel A.
    Merkies, Ingemar S. J.
    Faber, Catharina G.
    Waxman, Stephen G.
    MOLECULAR PAIN, 2015, 11
  • [26] NETWORK TOPOLOGY OF NAV1.7 MUTATIONS IN SODIUM CHANNEL-RELATED PAINFUL DISORDERS
    Kapetis, D.
    Yang, Y.
    Galbardi, B.
    Szklarczyk, R.
    Faber, C. G.
    Gerrits, M.
    Merkies, I. S. J.
    Dib-Hajj, S. D.
    Tononi, P.
    Sassone, J.
    Mantegazza, M.
    Waxman, S. G.
    Lauria, G.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 : S14 - S15
  • [27] General mechanism of spider toxin family I acting on sodium channel Nav1.7
    Fu-Chu Yuan
    Fu-De Sun
    Lin Zhang
    Biao Huang
    Hai-Long An
    Ming-Qiang Rong
    Can-Wei Du
    Zoological Research, 2022, (05) : 886 - 896
  • [28] Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7
    Xiao-yu Zhang
    Rui-yun Bi
    Peng Zhang
    Ye-hua Gan
    Acta Pharmacologica Sinica, 2018, 39 : 1716 - 1724
  • [29] General mechanism of spider toxin family I acting on sodium channel Nav1.7
    Yuan, Fu-Chu
    Sun, Fu-De
    Zhang, Lin
    Huang, Biao
    An, Hai-Long
    Rong, Ming-Qiang
    Du, Can-Wei
    ZOOLOGICAL RESEARCH, 2022, 43 (05) : 886 - 896
  • [30] Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis
    Pukkanasut, Piyasuda
    Jaskula-Sztul, Renata
    Gomora, Juan Carlos
    Velu, Sadanandan E.
    FRONTIERS IN PHARMACOLOGY, 2024, 15